Legal Representation
Attorney
Cheryl L. Foytlin
USPTO Deadlines
Application History
29 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 18, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Nov 13, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Nov 13, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Mar 29, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 27, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 27, 2017 | EXT4 | S | SOU EXTENSION 4 FILED |
| Mar 27, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Sep 27, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 26, 2016 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Sep 23, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 23, 2016 | EXT3 | S | SOU EXTENSION 3 FILED |
| Apr 13, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 12, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Apr 5, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 5, 2016 | EXT2 | S | SOU EXTENSION 2 FILED |
| Oct 1, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 30, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sep 30, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Sep 24, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 24, 2015 | EXT1 | S | SOU EXTENSION 1 FILED |
| Apr 7, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Feb 10, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 10, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 21, 2015 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 21, 2015 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Jan 5, 2015 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 5, 2015 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 25, 2014 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 22, 2014 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases; contraceptive preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005